Education and screening for colorectal cancer and hepatitis C
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)
This study is trying to see if educating patients aged 45-75 about colorectal cancer and hepatitis C can help them get screened for these conditions more often.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 350 (estimated) |
| Ages | 45 Years to 75 Years |
| Sex | All |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute Academic / other |
| Locations | 1 site (Tampa, Florida) |
| Trial ID | NCT06745895 on ClinicalTrials.gov |
What this trial studies
This intervention promotes concurrent screening for colorectal cancer (CRC) and hepatitis C virus (HCV) among patients aged 45-75 at Federally Qualified Health Centers (FQHCs). The MATCHES program focuses on educating patients about the importance of screening and ensuring they receive the necessary tests. The study aims to improve screening rates by targeting individuals who are not up to date with CRC screening and have never been screened for HCV. The intervention includes providing educational materials and support to facilitate participation in screening.
Who should consider this trial
Good fit: Ideal candidates are patients aged 45-75 receiving care at participating FQHC clinics who are not up to date with CRC screening and have never been screened for HCV.
Not a fit: Patients with a personal history of colorectal cancer or current symptoms suggestive of CRC will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly increase screening rates for colorectal cancer and hepatitis C, leading to earlier detection and improved patient outcomes.
How similar studies have performed: Other studies have shown success in increasing screening rates through educational interventions, making this approach promising but not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be receiving care at one of the participating FQHC clinics. * Participants must be 45-75 years of age. * Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months. * Participants must never have had Hepatitis C Virus (HCV) antibody screening. * Participants must be able to read, write, and understand English or Spanish. * Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating. * Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC). * Participants must be asymptomatic for HCV. * Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention. * Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM. * Participants completing qualitative interviews must be willing to be audio recorded. * Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months. * All Participants must be able to provide informed consent. Exclusion Criteria: * Participants that do not meet all Inclusion Eligibility requirements will be excluded.
Where this trial is running
Tampa, Florida
- Moffitt Cancer Center — Tampa, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Shannon Christy, PhD — Moffitt Cancer Center
- Study coordinator: Carol Boxtha
- Email: Carol.Boxtha@Moffitt.org
- Phone: 813-745-8963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.